Stay updated on Oral Elsubrutinib and Upadacitinib in Lupus Clinical Trial
Sign up to get notified when there's something new on the Oral Elsubrutinib and Upadacitinib in Lupus Clinical Trial page.

Latest updates to the Oral Elsubrutinib and Upadacitinib in Lupus Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.3%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe web page has been updated to reflect a new version, changing from v2.14.4 to v2.15.0.SummaryDifference1.0%
- Check30 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4 and removed a date of 2025-03-25 while adding a new date of 2025-01-14.SummaryDifference1.0%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check88 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference5%
- Check95 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.3%
Stay in the know with updates to Oral Elsubrutinib and Upadacitinib in Lupus Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Oral Elsubrutinib and Upadacitinib in Lupus Clinical Trial page.